**Rebeca Lorca 1,2, María Martín 1,2, Isaac Pascual 1,2,3,\*, Aurora Astudillo 3,4, Beatriz Díaz Molina 1,2, Helena Cigarrán 5, Elías Cuesta-Llavona 1,2, Pablo Avanzas 1,2,3, José Julían Rodríguez Reguero 1,2, Eliecer Coto 1,2,3, César Morís 1,2,3 and Juan Gómez 1,2**


Received: 15 June 2020; Accepted: 3 August 2020; Published: 5 August 2020

**Abstract:** Left ventricle non-compaction cardiomyopathy (LVNC) has gained great interest in recent years, being one of the most controversial cardiomyopathies. There are several open debates, not only about its genetic heterogeneity, or about the possibility to be an acquired cardiomyopathy, but also about its possible overdiagnosis based on imaging techniques. In order to better understand this entity, we identified 38 LVNC patients diagnosed by cardiac MRI (CMRI) or anatomopathological study that could underwent NGS-sequencing and clinical study. Anatomopathological exam was performed in eight available LVNC hearts. The genetic yield was 34.2%. Patients with negative genetic testing had better left ventricular ejection fraction (LVEF) or it showed a tendency to improve in follow-up, and a possible trigger factor for LVNC was identified in 1/3 of them. Nonetheless, cerebrovascular accidents occurred in similar proportions in both groups. We conclude that in LVNC there seem to be different ways to achieve the same final phenotype. Genetic testing has a good genetic yield and provides valuable information. LVNC without an underlying genetic cause may have a better prognosis in terms of LVEF evolution. However, anticoagulation to prevent cerebrovascular accident (CVA) should be carefully evaluated in all patients. Larger series with pathologic examination are needed to help better understand this entity.

**Keywords:** left ventricle non-compaction cardiomyopathy; non-ischemic cardiomyopathy; genetics; cardiac magnetic resonance
